Mind Medicine (MindMed) Inc
NASDAQ:MNMD

Watchlist Manager
Mind Medicine (MindMed) Inc Logo
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
Watchlist
Price: 7.32 USD 3.39% Market Closed
Market Cap: 536.8m USD
Have any thoughts about
Mind Medicine (MindMed) Inc?
Write Note

Mind Medicine (MindMed) Inc
EPS (Diluted)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Mind Medicine (MindMed) Inc
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
EPS (Diluted)
-$1
CAGR 3-Years
27%
CAGR 5-Years
16%
CAGR 10-Years
0%
Canopy Growth Corp
TSX:WEED
EPS (Diluted)
-CA$6
CAGR 3-Years
-28%
CAGR 5-Years
-3%
CAGR 10-Years
-46%
Sundial Growers Inc
NASDAQ:SNDL
EPS (Diluted)
CA$0
CAGR 3-Years
36%
CAGR 5-Years
37%
CAGR 10-Years
N/A
Cronos Group Inc
TSX:CRON
EPS (Diluted)
$0
CAGR 3-Years
50%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
K
Knight Therapeutics Inc
TSX:GUD
EPS (Diluted)
CA$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
C
Curaleaf Holdings Inc
CNSX:CURA
EPS (Diluted)
$0
CAGR 3-Years
-101%
CAGR 5-Years
-59%
CAGR 10-Years
N/A
No Stocks Found

Mind Medicine (MindMed) Inc
Glance View

Market Cap
536.8m USD
Industry
Pharmaceuticals

Mind Medicine (MindMed), Inc. operates as a neuro-pharmaceutical company that discovers, develops and deploys psychedelic medicines to improve health, promote wellness and alleviate suffering. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2015-05-04. The firm focuses on discovering, developing and deploying psychedelic-inspired medicines and therapies to address addiction and mental illness. The firm's commercial drug development programs includes lysergic acid diethylamide (LSD) experiential therapy, 18-methoxycoronaridine (18-MC) opioid withdrawal, LSD microdosing, methylenedioxymethamphetamine (MDMA), and dimethyltryptamine (DMT). The firm's subsidiaries include Mind Medicine, Inc., HealthMode, Inc., MindMed Pty Ltd. and MindMed GmbH.

MNMD Intrinsic Value
2.22 USD
Overvaluation 70%
Intrinsic Value
Price

See Also

What is Mind Medicine (MindMed) Inc's EPS (Diluted)?
EPS (Diluted)
-1.3 USD

Based on the financial report for Sep 30, 2024, Mind Medicine (MindMed) Inc's EPS (Diluted) amounts to -1.3 USD.

What is Mind Medicine (MindMed) Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
0%

Over the last year, the EPS (Diluted) growth was 35%. The average annual EPS (Diluted) growth rates for Mind Medicine (MindMed) Inc have been 27% over the past three years , 16% over the past five years .

Back to Top